Angiotensin AT1 receptor antagonism ameliorates murine retinal proteome changes induced by diabetes

Journal of Proteome Research

Volumn 8, Issue 12, 2009, Pages 5541-5549

  Gao, Ben Bo ^a   Phipps, Joanna A ^a   Bursell, Dahlia ^a   Clermont, Allen C ^a   Feener, Edward P ^a  

^a JOSLIN DIABETES CENTER   (United States)

Author keywords

Angiotensin AT1 receptor; Diabetes mellitus; Diabetic retinopathy; Proteome; Retina

Indexed keywords

2 AMINO 3 PHOSPHONOPROPIONIC ACID; 26S PROTEASE REGULATORY SUBUNIT S10B; 60S RIBOSOMAL PROTEIN L21; 60S RIBOSOMAL PROTEIN L23A; 9S RIBOSOMAL PROTEIN L12; ALDEHYDE REDUCTASE; ANGIOTENSIN 1 RECEPTOR; AP 3 COMPLEX SUBUNIT BETA 2; BETA CATENIN; CANDESARTAN HEXETIL; COATOMER PROTEIN; DUAL SPECIFICITY PHOSPHATASE 3; ELONGATION FACTOR 1 DELTA; ESTRADIOL 17 BETA DEHYDROGENASE 8; FATTY ACID SYNTHASE; FK506 BINDING PROTEIN 2; FK506 BINDING PROTEIN 4; GLYCINE TRANSFER RNA LIGASE; HEAT SHOCK 70 KDA PROTEIN 12A; INITIATION FACTOR 2; LONG CHAIN FATTY ACID COENZYME A LIGASE; MAGUK P55 SUBFAMILY MEMBER 2; NADH CYTOCHROME B5 REDUCTASE 3; PHOSDUCIN; PROTEIN PHOSPHATASE METHYLESTERASE 1; PROTEOME; UBIQUITIN CONJUGATING ENZYME; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL LYSATE; CONTROLLED STUDY; DIABETIC RETINOPATHY; MALE; MOUSE; NONHUMAN; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FOLDING; PROTEIN METABOLISM; PROTEOMICS; RECEPTOR INTRINSIC ACTIVITY; RETINA; SIGNAL TRANSDUCTION; STREPTOZOCIN DIABETES;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; APOPTOSIS; BENZIMIDAZOLES; DIABETES MELLITUS; DIABETIC RETINOPATHY; EYE PROTEINS; METABOLISM; MICE; MICE, INBRED C57BL; OXIDATIVE PHOSPHORYLATION; PROTEOME; PROTEOMICS; RETINA; STREPTOZOCIN; TETRAZOLES;

MURINAE; MUS;

EID: 71549153783     PISSN: 15353893     EISSN: None     Source Type: Journal    
DOI: 10.1021/pr9006415     Document Type: Article

References (45)

1. Antonetti, D. A.; Barber, A. J.; Bronson, S. K.; Freeman, W. M.; Gardner, T. W.; Jefferson, L. S.; Kester, M.; Kimball, S. R.; Krady, J. K.; LaNoue, K. F.; Norbury, C. C.; Quinn, P. G.; Sandirasegarane, L.; Simpson, I. A. Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes 2006, 55 (9), 2401-2411
2. Fortune, B.; Schneck, M. E.; Adams, A. J. Multifocal electroretinogram delays reveal local retinal dysfunction in early diabetic retinopathy. Invest. Ophthalmol. Visual Sci. 1999, 40 (11), 2638-2651
3. Clermont, A.; Bursell, S. E.; Feener, E. P. Role of the angiotensin II type 1 receptor in the pathogenesis of diabetic retinopathy: effects of blood pressure control and beyond. J. Hypertens. Suppl. 2006, 24 (1), S73-80.
4. Sjolie, A. K. Prospects for angiotensin receptor blockers in diabetic retinopathy. Diabetes Res. Clin. Pract. 2007, 76 (Suppl. 1), S31-9.
5. Nagisa, Y.; Shintani, A.; Nakagawa, S. The angiotensin II receptor antagonist candesartan cilexetil (TCV-116) ameliorates retinal disorders in rats. Diabetologia 2001, 44 (7), 883-888 (Pubitemid 32651735)
6. Phipps, J. A.; Clermont, A. C.; Sinha, S.; Chilcote, T. J.; Bursell, S. E.; Feener, E. P. Plasma kallikrein mediates angiotensin II type 1 receptor-stimulated retinal vascular permeability. Hypertension 2009, 53 (2), 175-181
7. Chaturvedi, N.; Sjolie, A. K.; Stephenson, J. M.; Abrahamian, H.; Keipes, M.; Castellarin, A.; Rogulja-Pepeonik, Z.; Fuller, J. H. Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus. Lancet 1998, 351 (9095), 28-31.
8. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38 BMJ, 1998, 317 (7160), 703-713
9. Chaturvedi, N.; Porta, M.; Klein, R.; Orchard, T.; Fuller, J.; Parving, H. H.; Bilous, R.; Sjolie, A. K. Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials. Lancet 2008, 372 (9647), 1394-1402
10. Sjolie, A. K.; Klein, R.; Porta, M.; Orchard, T.; Fuller, J.; Parving, H. H.; Bilous, R.; Chaturvedi, N. Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial. Lancet 2008, 372 (9647), 1385-1393
11. Mauer, M.; Zinman, B.; Gardiner, R.; Suissa, S.; Sinaiko, A.; Strand, T.; Drummond, K.; Donnelly, S.; Goodyer, P.; Gubler, M. C.; Klein, R. Renal and retinal effects of enalapril and losartan in type 1 diabetes. N. Engl. J. Med. 2009, 361 (1), 40-51.
12. Mohr, S.; Xi, X.; Tang, J.; Kern, T. S. Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients. Diabetes 2002, 51 (4), 1172-1179
13. Martin, P. M.; Roon, P.; Van Ells, T. K.; Ganapathy, V.; Smith, S. B. Death of retinal neurons in streptozotocin-induced diabetic mice. Invest. Ophthalmol. Visual Sci. 2004, 45 (9), 3330-3336
14. Brucklacher, R. M.; Patel, K. M.; VanGuilder, H. D.; Bixler, G. V.; Barber, A. J.; Antonetti, D. A.; Lin, C. M.; LaNoue, K. F.; Gardner, T. W.; Bronson, S. K.; Freeman, W. M. Whole genome assessment of the retinal response to diabetes reveals a progressive neurovascular inflammatory response. BMC Med. Genomics 2008, 1, 26.
15. Adachi-Uehara, N.; Kato, M.; Nimura, Y.; Seki, N.; Ishihara, A.; Matsumoto, E.; Iwase, K.; Ohtsuka, S.; Kodama, H.; Mizota, A.; Yamamoto, S.; Adachi-Usami, E.; Takiguchi, M. Up-regulation of genes for oxidative phosphorylation and protein turnover in diabetic mouse retina. Exp. Eye Res. 2006, 83 (4), 849-857 (Pubitemid 44292681)
16. Quin, G. G.; Len, A. C.; Billson, F. A.; Gillies, M. C. Proteome map of normal rat retina and comparison with the proteome of diabetic rat retina: new insight in the pathogenesis of diabetic retinopathy. Proteomics 2007, 7 (15), 2636-2650
17. Gao, B. B.; Stuart, L.; Feener, E. P. Label-free quantitative analysis of 1D-PAGE LC/MS/MS proteome: Application on angiotensin II stimulated smooth muscle cells secretome. Mol. Cell. Proteomics 2008, 7 (12), 2399-2409
18. Camon, E.; Barrell, D.; Lee, V.; Dimmer, E.; Apweiler, R. The Gene Ontology Annotation (GOA) Database - an integrated resource of GO annotations to the UniProt Knowledgebase. In Silico Biol. 2004, 4 (1), 5-6. (Pubitemid 38714506)
19. Harris, M. A.; Clark, J.; Ireland, A.; Lomax, J.; Ashburner, M.; Foulger, R.; Eilbeck, K.; Lewis, S.; Marshall, B.; Mungall, C.; Richter, J.; Rubin, G. M.; Blake, J. A.; Bult, C.; Dolan, M.; Drabkin, H.; Eppig, J. T.; Hill, D. P.; Ni, L.; Ringwald, M.; Balakrishnan, R.; Cherry, J. M.; Christie, K. R.; Costanzo, M. C.; Dwight, S. S.; Engel, S.; Fisk, D. G.; Hirschman, J. E.; Hong, E. L.; Nash, R. S.; Sethuraman, A.; Theesfeld, C. L.; Botstein, D.; Dolinski, K.; Feierbach, B.; Berardini, T.; Mundodi, S.; Rhee, S. Y.; Apweiler, R.; Barrell, D.; Camon, E.; Dimmer, E.; Lee, V.; Chisholm, R.; Gaudet, P.; Kibbe, W.; Kishore, R.; Schwarz, E. M.; Sternberg, P.; Gwinn, M.; Hannick, L.; Wortman, J.; Berriman, M.; Wood, V.; de la Cruz, N.; Tonellato, P.; Jaiswal, P.; Seigfried, T.; White, R. The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res. 2004, 32 (Database issue), D258-61. (Pubitemid 38081651)
20. Blondeau, F.; Ritter, B.; Allaire, P. D.; Wasiak, S.; Girard, M.; Hussain, N. K.; Angers, A.; Legendre-Guillemin, V.; Roy, L.; Boismenu, D.; Kearney, R. E.; Bell, A. W.; Bergeron, J. J.; McPherson, P. S. Tandem MS analysis of brain clathrin-coated vesicles reveals their critical involvement in synaptic vesicle recycling. Proc. Natl. Acad. Sci. U.S.A. 2004, 101 (11), 3833-3838
21. Gilchrist, A.; Au, C. E.; Hiding, J.; Bell, A. W.; Fernandez-Rodriguez, J.; Lesimple, S.; Nagaya, H.; Roy, L.; Gosline, S. J.; Hallett, M.; Paiement, J.; Kearney, R. E.; Nilsson, T.; Bergeron, J. J. Quantitative proteomics analysis of the secretory pathway. Cell 2006, 127 (6), 1265-1281
22. Ricci, J. E.; Munoz-Pinedo, C.; Fitzgerald, P.; Bailly-Maitre, B.; Perkins, G. A.; Yadava, N.; Scheffler, I. E.; Ellisman, M. H.; Green, D. R. Disruption of mitochondrial function during apoptosis is mediated by caspase cleavage of the p75 subunit of complex I of the electron transport chain. Cell 2004, 117 (6), 773-786
23. Blackshaw, S.; Fraioli, R. E.; Furukawa, T.; Cepko, C. L. Comprehensive analysis of photoreceptor gene expression and the identification of candidate retinal disease genes. Cell 2001, 107 (5), 579-589
24. Joussen, A. M.; Huang, S.; Poulaki, V.; Camphausen, K.; Beecken, W. D.; Kirchhof, B.; Adamis, A. P. In vivo retinal gene expression in early diabetes. Invest. Ophthalmol. Visual Sci. 2001, 42 (12), 3047-3057 (Pubitemid 33035308)
25. Gygi, S. P.; Rochon, Y.; Franza, B. R.; Aebersold, R. Correlation between protein and mRNA abundance in yeast. Mol. Cell. Biol. 1999, 19 (3), 1720-1730 (Pubitemid 29098230)
26. Ideker, T.; Thorsson, V.; Ranish, J. A.; Christmas, R.; Buhler, J.; Eng, J. K.; Bumgarner, R.; Goodlett, D. R.; Aebersold, R.; Hood, L. Integrated genomic and proteomic analyses of a systematically perturbed metabolic network. Science 2001, 292 (5518), 929-934 (Pubitemid 32422490)
27. Gao, B. B.; Clermont, A.; Rook, S.; Fonda, S. J.; Srinivasan, V. J.; Wojtkowski, M.; Fujimoto, J. G.; Avery, R. L.; Arrigg, P. G.; Bursell, S. E.; Aiello, L. P.; Feener, E. P. Extracellular carbonic anhydrase mediates hemorrhagic retinal and cerebral vascular permeability through prekallikrein activation. Nat. Med. 2007, 13 (2), 181-188
28. Gao, B. B.; Chen, X.; Timothy, N.; Aiello, L. P.; Feener, E. P. Characterization of the Vitreous Proteome in Diabetes without Diabetic Retinopathy and Diabetes with Proliferative Diabetic Retinopathy. J. Proteome Res. 2008, 7 (6), 2516-2525
29. Kowluru, R. A. Retinal metabolic abnormalities in diabetic mouse: comparison with diabetic rat. Curr. Eye Res. 2002, 24 (2), 123-128
30. Sharon, D.; Blackshaw, S.; Cepko, C. L.; Dryja, T. P. Profile of the genes expressed in the human peripheral retina, macula, and retinal pigment epithelium determined through serial analysis of gene expression (SAGE). Proc. Natl. Acad. Sci. U.S.A. 2002, 99 (1), 315-320
31. Brownlee, M. Biochemistry and molecular cell biology of diabetic complications. Nature 2001, 414 (6865), 813-820 (Pubitemid 34000785)
32. Barber, A. J.; Lieth, E.; Khin, S. A.; Antonetti, D. A.; Buchanan, A. G.; Gardner, T. W. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J. Clin. Invest. 1998, 102 (4), 783-791
33. Ejaz, S. Importance of pericytes and mechanisms of pericyte loss during diabetes retinopathy. Diabetes Obes. Metab. 2007, 10 (1), 56-63. (Pubitemid 350302431)
34. Takamura, Y.; Tomomatsu, T.; Kubo, E.; Tsuzuki, S.; Akagi, Y. Role of the polyol pathway in high glucose-induced apoptosis of retinal pericytes and proliferation of endothelial cells. Invest. Ophthalmol. Visual Sci. 2008, 49 (7), 3216-3223
35. Tewari, M.; Yu, M.; Ross, B.; Dean, C.; Giordano, A.; Rubin, R. AAC-11, a novel cDNA that inhibits apoptosis after growth factor withdrawal. Cancer Res. 1997, 57 (18), 4063-4069
36. Morris, E. J.; Michaud, W. A.; Ji, J. Y.; Moon, N. S.; Rocco, J. W.; Dyson, N. J. Functional identification of Api5 as a suppressor of E2F-dependent apoptosis in vivo. PLoS Genet. 2006, 2 (11), e196.
37. Ju,W. K.; Misaka, T.; Kushnareva, Y.; Nakagomi, S.; Agarwal, N.; Kubo, Y.; Lipton, S. A.; Bossy-Wetzel, E. OPA1 expression in the normal rat retina and optic nerve. J. Comp. Neurol. 2005, 488 (1), 1-10. (Pubitemid 40770825)
38. Wang, A. G.; Fann, M. J.; Yu, H. Y.; Yen, M. Y. OPA1 expression in the human retina and optic nerve. Exp. Eye Res. 2006, 83 (5), 1171-1178 (Pubitemid 44397037)
39. Alexander, C.; Votruba, M.; Pesch, U. E.; Thiselton, D. L.; Mayer, S.; Moore, A.; Rodriguez, M.; Kellner, U.; Leo-Kottler, B.; Auburger, G.; Bhattacharya, S. S.; Wissinger, B. OPA1, encoding a dynamin-related GTPase, is mutated in autosomal dominant optic atrophy linked to chromosome 3q28. Nat. Genet. 2000, 26 (2), 211-215 (Pubitemid 30764506)
40. Araujo, H.; Danziger, N.; Cordier, J.; Glowinski, J.; Chneiweiss, H. Characterization of PEA-15, a major substrate for protein kinase C in astrocytes. J. Biol. Chem. 1993, 268 (8), 5911-5920 (Pubitemid 23090927)
41. Renault, F.; Formstecher, E.; Callebaut, I.; Junier, M. P.; Chneiweiss, H. The multifunctional protein PEA-15 is involved in the control of apoptosis and cell cycle in astrocytes. Biochem. Pharmacol. 2003, 66 (8), 1581-1588 (Pubitemid 38373349)
42. Nagai, N.; Izumi-Nagai, K.; Oike, Y.; Koto, T.; Satofuka, S.; Ozawa, Y.; Yamashiro, K.; Inoue, M.; Tsubota, K.; Umezawa, K.; Ishida, S. Suppression of diabetes-induced retinal inflammation by blocking the angiotensin II type 1 receptor or its downstream nuclear factor-kappaB pathway. Invest. Ophthalmol. Visual Sci. 2007, 48 (9), 4342-4350 (Pubitemid 351261068)
43. Gilbert, R. E.; Kelly, D. J.; Cox, A. J.; Wilkinson-Berka, J. L.; Rumble, J. R.; Osicka, T.; Panagiotopoulos, S.; Lee, V.; Hendrich, E. C.; Jerums, G.; Cooper, M. E. Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes. Diabetologia 2000, 43 (11), 1360-1367
44. Horio, N.; Clermont, A. C.; Abiko, A.; Abiko, T.; Shoelson, B. D.; Bursell, S. E.; Feener, E. P. Angiotensin AT(1) receptor antagonism normalizes retinal blood flow and acetylcholine-induced vasodilatation in normotensive diabetic rats. Diabetologia 2004, 47 (1), 113-123
45. Kurihara, T.; Ozawa, Y.; Nagai, N.; Shinoda, K.; Noda, K.; Imamura, Y.; Tsubota, K.; Okano, H.; Oike, Y.; Ishida, S. Angiotensin II Type 1 receptor signaling contributes to synaptophysin degradation and neuronal dysfunction in the diabetic retina. Diabetes 2008, 57 (8), 2191-2198